BRIEF published on 06/08/2026 at 09:41, 1 month 24 days ago Sofinnova's threshold crossing in INVENTIVA Voting Rights Threshold Crossing New Actions Inventiva Sofinnova Partners
BRIEF published on 06/02/2026 at 14:35, 2 months ago Inventiva Resumes Trading on Euronext Paris Euronext Paris Debt Financing Trading Resumption Inventiva MASH Treatment
PRESS RELEASE published on 06/02/2026 at 14:30, 2 months ago Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris Inventiva announces trading resumption of its ordinary shares on Euronext Paris following Debt Financing Transaction and ADS Offering Euronext Paris Ordinary Shares Clinical-Stage Biopharmaceutical Trading Resumption Inventiva
BRIEF published on 06/02/2026 at 07:35, 2 months ago Inventiva Halts Trading of Ordinary Shares on Euronext Paris Euronext Paris Trading Halt Inventiva MASH Treatment Nadsaq
BRIEF published on 06/02/2026 at 07:35, 2 months ago Temporary suspension of Inventiva shares on Euronext Paris Euronext Paris Funding Nasdaq Inventiva Temporary Suspension
PRESS RELEASE published on 06/02/2026 at 07:30, 2 months ago Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris for a proposed financing transaction. Trading to resume after communication Euronext Paris Trading Halt Clinical Trial Inventiva Metabolic Dysfunction
BRIEF published on 05/26/2026 at 22:05, 2 months 6 days ago Inventiva Announces its First Quarter 2026 Financial Results Financial Results Treasury Biopharmaceutical Inventiva NATiV3
PRESS RELEASE published on 05/26/2026 at 22:00, 2 months 6 days ago Inventiva Reports 2026 First Quarter Financial Information¹ Inventiva reports first quarter 2026 financial information, with cash and cash equivalents at €75.0 million and short-term deposits at €121.5 million. Explore company's financial results and upcoming milestones Financial Information Inventiva NATiV3 Cash Equivalents Short-term Deposits
BRIEF published on 05/21/2026 at 22:05, 2 months 11 days ago Inventiva to Present at 2026 Jefferies Global Healthcare Conference Biopharmaceutical Inventiva Lanifibranor MASH Treatment Jefferies Conference
BRIEF published on 05/21/2026 at 22:05, 2 months 11 days ago Inventiva at the 2026 Jefferies Global Healthcare Conference Biopharmaceutical Inventiva MASH Lanifibranor Jefferies Conference
Published on 08/01/2026 at 01:20, 1 day 13 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 13 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 14 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 1 day 15 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/02/2026 at 08:15, 6 hours 57 minutes ago Holcim signs agreement to divest its business in the Philippines
Published on 08/01/2026 at 16:35, 22 hours 37 minutes ago HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 1 day 19 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 1 day 20 hours ago Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 21:00, 1 day 18 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:13, 1 day 19 hours ago Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 1 day 20 hours ago Covivio Hotels - 2026 Half-year financial report
